- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/14 - Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
Patent holdings for IPC class C07D 239/14
Total number of patents in this class: 46
10-year publication summary
4
|
6
|
5
|
4
|
3
|
5
|
4
|
2
|
1
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Sharp & Dohme LLC | 3749 |
5 |
F. Hoffmann-La Roche AG | 7929 |
3 |
The Regents of the University of California | 19868 |
3 |
Saint Louis University | 298 |
3 |
Shionogi & Co., Ltd. | 860 |
3 |
Sanofi | 4038 |
3 |
Nippon Shinyaku Co., Ltd. | 327 |
2 |
Roche Palo Alto LLC | 74 |
2 |
Shanghai ChemPartner Co., Ltd. | 3 |
2 |
Inspirna, Inc. | 38 |
2 |
Bristol-myers Squibb Company | 4878 |
1 |
Hoffmann-La Roche Inc. | 3405 |
1 |
Merck Sharp & Dohme Corp. | 2200 |
1 |
Wisconsin Alumni Research Foundation | 3870 |
1 |
Araxes Pharma LLC | 90 |
1 |
Arrowhead Pharmaceuticals, Inc. | 298 |
1 |
BioCryst Pharmaceuticals, Inc. | 176 |
1 |
Constellation Pharmaceuticals, Inc. | 212 |
1 |
Cystic Fibrosis Foundation Therapeutics, Inc. | 7 |
1 |
Rohm and Haas Electronic Materials Korea Ltd. | 330 |
1 |
Other owners | 8 |